Patient perspectives following pharmacogenomics results disclosure in an integrated health system.

Pharmacogenomics 2018 03 22;19(4):321-331. Epub 2018 Feb 22.

Center for Personalized Medicine, NorthShore University HealthSystem, 1001 University Place, Suite 160, Evanston, IL 60201, USA.

Aim: To assess patient perceptions and utilization of pharmacogenomics (PGx) testing in an integrated community health system.

Methods: Fifty-seven patients completed an online survey assessing their experiences with PGx testing offered through two methods: a designated PGx clinic or direct access in-home testing.

Results: The majority of participants perceived PGx testing as helpful in their healthcare and reported understanding their results. Some had concerns about privacy and discrimination; most lacked familiarity with the Genetic Information Nondiscrimination Act. There were no significant differences in views between participants tested through either model.

Conclusion: Participants reported value in both methods of PGx testing. Patient experiences, understanding and result utilization will play an important role in informing future development and implementation of PGx programs.

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2017-0191DOI Listing
March 2018
7 Reads

Publication Analysis

Top Keywords

pgx testing
16
pgx
6
access in-home
4
in-home testingresults
4
understanding result
4
testingresults majority
4
majority participants
4
perceived pgx
4
participants perceived
4
experiences understanding
4
direct access
4
result utilization
4
testing offered
4
differences views
4
experiences pgx
4
offered methods
4
methods designated
4
pgx clinic
4
utilization will
4
designated pgx
4

References

(Supplied by CrossRef)

Filipski KK et al.
Pharmgenomics Pers. Med. 2017

Similar Publications